This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/drugbank/drug/DB06850/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n11http://linked.opendata.cz/resource/drugbank/drug/DB06850/identifier/pdb/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB06850/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB06850/identifier/pubchem-substance/

Statements

Subject Item
n2:DB06850
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB06850 n13:DB06850
dcterms:title
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide
adms:identifier
n8:44141860 n9:99443321 n10:DB06850 n11:11U
n3:IUPAC-Name
n4:271B57F9-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B57FF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B57FE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B57FB-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B57FC-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B57FD-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B57F7-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B57F8-363D-11E5-9242-09173F13E4C5 n4:271B57F5-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B57F6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5805-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5806-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5800-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5801-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5803-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5802-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5804-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B580B-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B580D-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B580E-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B580A-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5809-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B580C-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B57FA-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5807-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5808-363D-11E5-9242-09173F13E4C5